Send us a text

This week on The Rounds Table we’re deepening our understanding of cardiovascular disease management through covering two exciting new articles. Kieran and Paxton break it down for listeners. Last season we covered FOURIER/evolocumab and the reduction of cardiovascular events through aggressive lipid lowering with PCSK-9 inhibitors. Do treatments that target inflammation without affecting lipid levels ...

The post CANVASsing for Healthy Hearts: Canakinumab for Atherosclerosis and Canaglifozin for Cardiovascular Risk Reduction appeared first on Healthy Debate.